Andere talen Beijing Luzhu Biotechnology Co., Ltd.

Aandelen

2480

CNE100005YD8

Beurs gesloten - Hong Kong S.E. Andere beurzen 10:08:10 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
24,5 ^HKD	+0,41%		-3,54%	-18,06%

24/04	Beijing Luzhu Biotechnology boekt lager verlies in 2023 temidden van hogere overige inkomsten	MT
15/03	Beijing Luzhu Biotechnology Co, Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

59,729,296 Domestic Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	07/05
132,333,736 H Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-MAY-2024.	07/05
Beijing Luzhu Biotechnology Posts Lower Loss in 2023 Amid Higher Other Income	24/04
Beijing Luzhu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Luzhu Biotechnology Completes H Share Full Circulation	31/01
Luzhu Biotechnology Gets Hong Kong Bourse's Nod to List Converted Shares	30/01
Beijing Luzhu Biotechnology Completes Patient Enrollment for Phase 3 Trial for Shingles	19/01
Luzhu Biotech Completes Enrollment of Subjects for Phase III Trial of Shingles Vaccine in China	18/01
Beijing Luzhu Biotechnology Co., Ltd. Announces the Completion of Enrollment of Subjects for Phase III Clinical Trial of LZ901 in the PRC	18/01
4,786,400 H Shares of Beijing Luzhu Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	07/11
Luzhu Biotechnology Begins Phase III Clinical Trial of Shingles Drug	29-09-23
Beijing Luzhu Biotechnology Co., Ltd. Announces Initiation of Phase III Clinical Trial and Completion of Enrollment of First Group of Subjects for LZ901 in the PRC	28-09-23
Beijing Luzhu Biotechnology Co., Ltd.(SEHK:2480) added to S&P Global BMI Index	18-09-23
Beijing Luzhu Biotechnology Slashes H1 Loss	22-08-23
Beijing Luzhu Biotechnology to Shrink H1 Loss by 87%	09-08-23
Beijing Luzhu Biotechnology Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023	09-08-23
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs	26-06-23
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement	26-06-23
Luzhu Biotechnology CFO Steps Down	15-06-23
Beijing Luzhu Biotechnology Co., Ltd. Announces Change in Chief Executive Officer	14-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Beijing Luzhu Biotechnology Co., Ltd.

Aandelen

2480

CNE100005YD8

Andere talen

Filters